Immunitrack Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 16


  • Latest Deal Type
  • M&A

Immunitrack General Information


Developer of AI-based prediction and assessment platform designed to assist biotech and pharma companies. The company offers contracted research to the pharmaceutical industry predicting how the immune system reacts to different pharmaceuticals, by producing reagents that can be used to examine the immune system's reaction, enabling biotech and pharma companies to produce new biologics and vaccines easily.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Lersø Parkallé 42
  • 2100 Copenhagen
  • Denmark

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunitrack Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 10-Apr-2023 00.000 Completed Generating Revenue
5. Accelerator/Incubator 24-Jun-2020 00.000 Completed Generating Revenue
4. Grant 08-Aug-2019 00000 00.000 Completed Generating Revenue
3. Seed Round 05-Jun-2018 00.000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 24-Nov-2016 Completed Generating Revenue
1. Spin-Off 01-Jan-2013 Completed Startup
To view Immunitrack’s complete valuation and funding history, request access »

Immunitrack Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunitrack Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Accelerace Accelerator/Incubator Minority 000 0000 000000 0
Blenheim Capital (Investor) Venture Capital Minority 000 0000 000000 0
EASME - EU Executive Agency for SMEs Corporation Minority 000 0000 000000 0
Eurostars Other 000 0000 000000 0
Invest Horizon Accelerator/Incubator 000 0000 000000 0
To view Immunitrack’s complete investors history, request access »

Immunitrack FAQs

  • When was Immunitrack founded?

    Immunitrack was founded in 2013.

  • Who is the founder of Immunitrack?

    Stephan Thorgrimsen Ph.D and Sune Justensen Ph.D are the founders of Immunitrack.

  • Where is Immunitrack headquartered?

    Immunitrack is headquartered in Copenhagen, Denmark.

  • What is the size of Immunitrack?

    Immunitrack has 16 total employees.

  • What industry is Immunitrack in?

    Immunitrack’s primary industry is Decision/Risk Analysis.

  • Is Immunitrack a private or public company?

    Immunitrack is a Private company.

  • What is Immunitrack’s current revenue?

    The current revenue for Immunitrack is 000000.

  • How much funding has Immunitrack raised over time?

    Immunitrack has raised $4.12M.

  • Who are Immunitrack’s investors?

    Accelerace, Blenheim Capital (Investor), EASME - EU Executive Agency for SMEs, Eurostars, and Invest Horizon have invested in Immunitrack.

  • When was Immunitrack acquired?

    Immunitrack was acquired on 10-Apr-2023.

  • Who acquired Immunitrack?

    Immunitrack was acquired by Eli Lilly and Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »